CVS Health announced plans to split into two independent companies, separating its retail pharmacy operations from its insurance and healthcare services businesses. The move, revealed after months of internal strategic review, is set to take effect in the first half of 2028, according to people familiar with the matter cited by the Wall Street Journal.
The decision marks a dramatic shift for the $400 billion healthcare giant, whose red-lettered pharmacies are a familiar sight across the United States. Under the plan, one company—CVS Pharmacy—will operate the approximately 9,000 retail locations, in-store clinics, and mail-order pharmacies. The other, retaining the CVS Health name, will include the insurance provider Aetna, pharmacy-benefit manager Caremark, specialty pharmacies, and healthcare services such as Oak Street Health and Signify Health.
The breakup will unwind one of the most significant vertical integration experiments in the U.S. healthcare sector. CVS’s acquisition of Aetna in 2018, valued at nearly $70 billion, had brought together insurance, pharmacy benefits, and retail pharmacy operations under a single corporate umbrella. The deal was seen as a defining moment in health-industry consolidation, aiming to create a seamless healthcare experience for consumers.
According to the Wall Street Journal, the decision to split was made by a small group of top CVS executives who spent months in a confidential strategic review. The plan was kept secret until its announcement, reflecting the radical nature of the move. CVS Health CEO David Joyner, who took the top job in 2024, had previously rejected the idea of a split, making the reversal even more notable.
The split will see CVS Pharmacy focus exclusively on retail and pharmacy services, while the remaining CVS Health entity will concentrate on insurance, pharmacy-benefit management, and healthcare services. The company has not yet detailed how the separation will be executed or what the financial implications will be for shareholders and employees.
The Wall Street Journal reports that the breakup is intended to simplify operations and allow each company to focus on its core strengths. The move also comes at a time when the healthcare industry is undergoing significant changes, with increased competition and regulatory scrutiny of large, vertically integrated organizations.
CVS Health’s decision to reverse its previous strategy comes amid broader questions about the effectiveness of combining insurance, pharmacy, and retail operations. While the company’s integrated model was initially touted as a way to improve efficiency and patient outcomes, it has faced challenges in delivering on those promises and adapting to shifting industry dynamics.
Industry analysts are closely watching how the split will impact CVS’s market position and the broader healthcare landscape. The separation could have ripple effects for competitors and partners, as well as for millions of American consumers who rely on CVS’s services.
Why it matters
The CVS Health split is one of the most significant corporate restructurings in the healthcare sector in recent years, reversing a decade-long trend toward consolidation. The decision to separate retail pharmacies from insurance and pharmacy-benefit operations directly impacts how care is delivered and paid for across the United States, and challenges the logic behind previous mega-mergers such as CVS’s own acquisition of Aetna.
By dividing into two focused entities, CVS is responding to mounting pressures from regulators, competitors, and changing consumer expectations. According to the Wall Street Journal, the move is a response to operational complexities and the need to adapt to a rapidly evolving healthcare environment. The decision will affect not only CVS’s 9,000 retail locations and their customers but also major players in insurance, pharmacy benefits, and healthcare services.
As the separation unfolds, stakeholders across the healthcare industry will be watching closely. The outcome could influence future strategies for other integrated healthcare giants and shape the competitive landscape for years to come. With the split scheduled for completion by the first half of 2028, attention will turn to how each new company defines its mission and navigates the challenges ahead.
The image accompanying this article is an AI-generated illustrative depiction inspired by the actual scene of the event.
